CN107402300A - A kind of method of quick discriminating human parathyroid - Google Patents

A kind of method of quick discriminating human parathyroid Download PDF

Info

Publication number
CN107402300A
CN107402300A CN201710650822.8A CN201710650822A CN107402300A CN 107402300 A CN107402300 A CN 107402300A CN 201710650822 A CN201710650822 A CN 201710650822A CN 107402300 A CN107402300 A CN 107402300A
Authority
CN
China
Prior art keywords
pth
antibody
detection
test paper
parathyroid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201710650822.8A
Other languages
Chinese (zh)
Other versions
CN107402300B (en
Inventor
邹贤
朱利国
程晓青
范俊
朱国华
戴军
包建东
高芸
王国瑞
孙志强
李秀龙
周彬
曹亚琴
杨克勤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wuxi Jiangyuan industrial technology and Trade Co.,Ltd.
Original Assignee
Jiangsu Institute of Nuclear Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Institute of Nuclear Medicine filed Critical Jiangsu Institute of Nuclear Medicine
Priority to CN201710650822.8A priority Critical patent/CN107402300B/en
Publication of CN107402300A publication Critical patent/CN107402300A/en
Application granted granted Critical
Publication of CN107402300B publication Critical patent/CN107402300B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/533Production of labelled immunochemicals with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention discloses a kind of method of quick discriminating human parathyroid, it is determined in prepare liquid by parathyroid hormone (PTH) fluorescence immune chromatography test paper and realized in a manner of PTH contents, for the test paper by double antibody sandwich method and fluorescence immune chromatography technology for detection people PTH, the antibody is prepared using specific epitope peptide.The present invention can detect the people PTH in determinand exactly, easy to operate, quick, detection range is wide, it is specific it is high, sensitivity is good.

Description

A kind of method of quick discriminating human parathyroid
Technical field
The invention belongs to field of immunodetection, and in particular to a kind of method of quick discriminating human parathyroid.
Background technology
Thyroid cancer is the most common malignant tumour of incidence, and most fast pernicious swollen of incidence of disease growth rate in recent years One of knurl, thyroid cancer have become the fifth-largest common cancer of women.The treatment of thyroid cancer is mainly controlled with surgical operation Based on treatment, row thyroid gland cut entirely it is postoperative should determine parathyroid function situation as early as possible, take specific aim measure carry out prevent and treat first shape Other adenasthenia.If unexpected during operation cut off parathyroid gland, the blood calcium concentration of patient can be reduced substantially, trigger brothers to take out Jerk, or even threat to life.The incidence of the temporary hypocalcemia of document report L thyroxine tab is 0.3~86%, permanent Hypocalcemia is 0~13%.
PTH is secreted by chief cell, is had the function that to adjust and is kept serum calcium in normal level.How It is a great problem that parathyroid gland is effectively avoided damage in surgical procedure.Protection technique includes the knowledge of parathyroid gland in parathyroidectomy Not, the parathyroid gland that becomes more meticulous protection operating technology, the aspect of remedial parathyroid gland autotransplanting technology three.The identification of parathyroid gland It is a step of parathyroid gland protection most critical in art.There are thyroid gland, fat, lymph due to parathyroid gland body small volume, around it Knot, thymus gland, muscle etc. are organized, and are recognized and are had difficulties in art.Even if the accuracy rate of experienced surgeon naked eyes identification Only nearly 70%, up to 9~19% parathyroid gland accident resection rate in thyroid gland art be present.
Frozen section is still the goldstandard for differentiating parathyroid gland at present.But this needs cut-out Parathyroid Tissue, art Middle stand-by period length, expense is expensive, is also examined in the presence of 1.3% error rate, the parathyroid hormone (PTH) of FNA tissue eluent Survey, the method for differentiating parathyroid gland in preoperative and art, existing document report.Multiple studies have shown that parathyroid gland puncturing tissue The PTH values of eluent are detected by the PTH of FNA tissue eluent and differentiated in art apparently higher than non-Parathyroid Tissue Parathyroid Tissue, simple to operate, Sensitivity and Specificity is high, and fool proof.PTH detection is generally by electrification at present Learn it is luminous carry out, need large-scale detection device, detection time needs more than half an hour plus the shipping time, and such popularization and application are in distress Degree.
Immunochromatography technique is a kind of unique immunoassay formats for coming across the initial stage eighties, and it is generally fine with strip Dimension chromatographic material is solid phase, makes sample solution swimming on chromatography strip by capillarity, and make the determinand in sample simultaneously The immune response of highly-specific highly compatibility occurs for the acceptor (such as antibody or antigen) with being directed to determinand on chromatographic material, chromatographs Immune complex is enriched with or is trapped in the certain area (detection band) of chromatographic material in journey, and using by enzyme reaction or directly can The label (such as collaurum) of range estimation and obtain intuitively experimental result (such as showing different colors).And free label is then Detection band is crossed, reaches the purpose being automatically separated with binding label.The common trace labelling particle of immunochromatography technique has glue Body gold, latex, electroselenium, gelatin etc., wherein being collaurum with most successful label.But colloidal gold immunochromatographimethod tries Following defect be present in paper slip:
(1) colloid gold label process is Electrostatic Absorption process, is a kind of physical absorption, therefore less stable in the liquid phase, The protein molecular often resulted on marked comes off once more.
(2) testing result brings judgement by showing single aubergine bar, and color is single, it is difficult to realizes more inspections and connection Inspection.
(3) only when gold grain gathers it is a certain amount of when, people's naked eyes are just it is observed that purplish red band, and the coloured panel It is little with background contrasts, so as to limit detection sensitivity.
(4) different matrix of materials effects is obvious, and ambient interferences are very big.
(5) detection sensitivity is relatively low.
(6) quantitative detection can not be realized.
Also occurs the detection method using quantum dot mark fast immune chromatographic test paper bar at present, but the method is not The quantitative detection to detectable substance can be realized.
In addition, in the horizontal method of immunity of detection PTH, still lacking can Gao Ling in double-antibody sandwich measure The combination of quick, high specific detection, find the more particularly suitable PTH epitope peptides with immunogenicity, prepare it is specific PTH antigens and antibody are also the emphasis for needing to solve.
The content of the invention
The technical problem to be solved in the present invention is to overcome deficiencies of the prior art, there is provided a kind of high sensitivity and High specific, in batch, batch between error is small, simple to operate, cost is low quick discriminating human parathyroid method.
Specifically, there is provided a kind of method of quick discriminating human parathyroid, it comprises the following steps:
1) in vitro doubtful Parathyroid Tissue is sampled with syringe needle FNA, connection note in syringe needle rear after sampling Emitter;
2) solution conduit containing PBS is taken, is balanced to room temperature, the syringe after FNA is stretched into buffer solution, Mixing is fully washed by Smoking regime, testing sample is made;
3) above-mentioned testing sample is added in the sample application zone of human parathyroid hormone (PTH) fluorescence immune chromatography test paper, in incubating Change membrane chromatographic in device to react;
4) reacted fluorescence immune chromatography test paper and calibration card are inserted into inserting for Portable fluorescence immune quantitative analyzer Bayonet socket, runs instrument, and the automatic Card Reader of instrument provides quality control band C values and detection band T values in fluorescence immune chromatography test paper;
5) C is worked as<When 10000, it is that invalid detection detects, it is necessary to re-replace test paper to represent result;
It is as a result the positive as T/C >=0.2, shows that it is Parathyroid Tissue to puncture thing;
Work as T/C<It is as a result feminine gender when 0.2, shows to puncture the non-Parathyroid Tissue of thing.
Preferably, the puncture time in step 1) is 3 times, syringe needle 26-gague, and syringe volume is 1ml.
Preferably, PBS volume is 200 μ l in solution conduit in step 2), and step 3) adds the volume of testing sample For 60 μ l.
Preferably, the fluorescence immune chromatography test paper passes through double antibody sandwich method and fluorescence immune chromatography technology for detection people PTH, wherein:
The double antibody sandwich method is used as detection antibody, institute using the first PTH monoclonal antibodies for being marked with fluorescent microsphere The first PTH monoclonal antibodies are stated to prepare by the use of one in people PTH epitope peptides (1) and (2) as antigen;And
The double antibody sandwich method is using the 2nd PTH monoclonal antibodies as capture antibody, the second monoclonal antibody Prepared by the use of another in people PTH epitope peptides (1) and (2) as antigen;
The people PTH epitope peptides (1) and (2) are respectively:
(1):ERVEWLRKKLQ(SEQ ID NO:2)
(2):RKKEDNVLVESHEKSLGEAD(SEQ ID NO:3).
Further, the monoclonal antibody is the antigen being prepared by PTH epitope peptides and carrier protein couplet It is prepared.
Preferably, the fluorescent material on the fluorescent microsphere is rare earth ion europium;
Preferably, the micro-sphere material of the fluorescent microsphere is polystyrene, polymethyl methacrylate or methacrylic acid The copolymer of methyl esters.
Preferably, the test paper has a bottom plate, and on which floor plate along using when chromatography direction successively with the side of contact Formula is provided with:Sample pad, pad, nitrocellulose filter, blotting paper, the pad, which is provided with the mark, to be had The first PTH monoclonal antibodies, the nitrocellulose filter includes detection band and quality control band, and the detection band is coated with described Two PTH monoclonal antibodies, the quality control band, which is fixed with, to mark the first PTH monoclonal antibodies having special with described Property combine antiantibody.
Preferably, the bottom plate does not have photoluminescent property.
Preferably, the antiantibody is sheep anti-mouse igg monoclonal antibody or rabbit anti-mouse igg monoclonal antibody.
Further, the present invention also provides a kind of method for preparing the fluorescence immune chromatography test paper, and it includes following step Suddenly:
1) the first PTH monoclonal antibodies for being marked with fluorescent microsphere are provided;
2) pad is provided, wherein being combined with the first PTH monoclonals of the mark fluorescent microballoon on the pad Antibody;
3) nitrocellulose filter is provided, wherein being fixed on the nitrocellulose filter along chromatography direction interval when using 2nd PTH monoclonal antibodies and antiantibody, to form detection band and quality control band respectively;
4) the sample pad, pad, described is being set with the way of contact successively along chromatography direction when using on bottom plate Nitrocellulose filter, blotting paper, so as to which the fluorescence immune chromatography test paper be made.
The step 1) includes:
Fluorescent microsphere is washed using pH7.2-7.6 MES activation buffers, adds carbodiimide (EDC) and N- hydroxyl ambers Amber acid imide (NHS), certain time is reacted at room temperature, wash fluorescent microsphere, answered with 0.05M pH7.2-7.6 phosphate buffer Labelled antibody is added after molten, is reacted at room temperature 2 hours, adds the phosphate-buffered of the 0.05M pH7.2-7.6 containing 10%BSA Liquid, react at room temperature 30 minutes, fluorescent microsphere is washed, with containing 1%BSA, 0.1%Tween-20,0.05M pH7.2-7.6 phosphorus Phthalate buffer is redissolved to original volume, is quantitatively sprayed on pad, and 35-38 DEG C of lucifuge is dried 1 hour, is added drier and is sealed up for safekeeping It is standby.
In the step 3), the detection band and Quality Control spaced 3mm to 8mm, the 2nd PTH monoclonal antibodies and The coating concentration of the antiantibody is respectively 0.5~2mg/ml.
The present invention has the positive effect that compared with prior art:
(1) detection sample need to be sent to the laboratory of corresponding unit by the detection for PTH at present, be taken in testing instruments 15-20 minutes.Examined even if the method for quick identification of the present invention uses, by fine-needle puncturing technique, Fast Detection Technique and portable Formula Instrumental Analysis is combined, and the whole detection process time is short, and operative doctor can be made to leave operating room with regard to that can be rapidly completed first The discriminating of gland by shape.
(2) people's PTH epitope peptides of the invention have good antigenicity, can with the antigen-immunized animal of its preparation Produce the monoclonal antibody and polyclonal antibody of high degree of specificity.The antibody can be tied high special with the PTH in sample Close.
(3) fluorescence analysis are combined by the present invention with flash chromatography immunological technique, pass through people's PTH fluorescence immune chromatographies People PTH, easy to operate, quick, the PTH in 5 minutes in quick detection puncturing tissue liquid in test paper detection determinand, and Detection range is wide, it is specific it is high, sensitivity is good, is provided quickly, accurately and the section that can be achieved with operating room for surgeon Parathyroid gland discrimination method, in order to which preferably protection parathyroid gland, the reduction postoperative parathyroid function of patient subtract in art The incidence moved back, shorten the hospital stays, reduce medical expense.
(4) present invention is touched during the fluorescence immune chromatography test paper of the people PTH is prepared by largely testing Rope, optimize the preparation condition of each side so that when being detected with the fluorescence immune chromatography test paper of the present invention, fluorescence signal-to-background ratio Greatly improve, so as to improve detection sensitivity and credible result degree;In addition, detection band and Quality Control of the present invention also by test paper The change of the fluorescence intensity ratio of band carrys out the content of PTH in response sample, and this only examines or check detection band with traditional chromatographic technique Absolute fluorescence intensity is compared, and is reduced the influence of external condition and background etc. to the full extent, is further increased testing result Confidence level.
(5) the currently used main CLIA of PTH detection methods, CLIA methods accuracy and sensitivity are all higher, but to instrument The requirement of device equipment and operating personnel are too high, and reagent cost is also more expensive.We develop fluorescence immune chromatography test paper bar have compared with High sensitivity and specificity, batch in, batch between error it is small, with CLIA methods detection acquired results be not significantly different, comply fully with Clinical practice requirement, but it is simple to operate, small volume, it is easy to carry, is easy to preserve.Can using the fluorescence immune chromatography test paper bar Realize that quick, single part is quantitatively detected, be more suitable for the needs of clinical examination, while realize the industrialization of detecting instrument and reagent, Reach preferable Social benefit and economic benefit, clinic popularization and application.
Brief description of the drawings
Fig. 1 is the diagrammatic cross-section of fluorescence immune chromatography test paper along its length in embodiment 4;
Fig. 2 is fluorescence immune chromatography test paper floor map in embodiment 4.
Reference is expressed as in figure:1- bottom plates, 2- nitrocellulose filters, 3- blotting papers, 4- sample pads, 5- pads, 6- quality control bands, 7- detection bands.
Embodiment
The present invention is described in further detail below in conjunction with the accompanying drawings, to make those skilled in the art with reference to specification text Word can be implemented according to this.
Embodiment 1:People's PTH epitope peptides
People PTH specifically described herein is known in the art, and complete PTH is the single polypeptide chain containing 84 amino acid Form, molecular weight is about 9500 dalton.Its amino acid sequence be it is known in the art, can be in the specialized databases such as NCBI Find, particular sequence is as follows:
Mankind PTH (1-84):
SVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNFVALGAPLAPRDAGSQRPRKKEDNVLVESHEKSLGEADKADVNV LTKAKSQ(SEQ ID NO:1)
The present inventor gropes by substantial amounts of theoretical research and experiment, and final screening, which obtains two kinds, to be had well Antigenic epitope peptide.
PTH epitope peptides (1) are one section of peptide fragments containing 11 amino acid of the N-terminal 19-29 positions of people's PTH polypeptides, from And form the epitope peptide (1) containing 11 amino acid:ERVEWLRKKLQ(SEQ ID NO:2)
PTH epitope peptides (2) include the peptide fragment of people PTH C-terminals the 52nd to the 71st, so as to form containing 21 amino The epitope peptide (2) of acid:RKKEDNVLVESHEKSLGEAD(SEQ ID NO:3)
The characteristics of the two peptide fragments are respectively provided with hydrophily, antigenicity by force and are readily synthesized.
Epitope peptide is prepared by the more automatic peptide synthesizers of American AB I431A types, by Solid phase synthesis, and passes through The synthesized epitope peptide sequence of peptide sequence measure identification.The purity of peptide fragment can be entered with thin-layer chromatography and high performance liquid chromatography Row evaluation, and determine the concentration of epitope peptide.
Embodiment 2:The preparation of PTH antibody
The PTH epitope peptides (1) of the gained of embodiment 1 and (2) are connected with carrier protein respectively immune with anti-to prepare Former (1) and (2), animal is immunized respectively using gained antigen (1) and (2), so as to prepare specific monoclonal using antigen (1) Antibody and polyclonal antibody, and prepare specific monoclonal antibody and polyclonal antibody using antigen (2).
1. the preparation of antigen:PTH peptide fragments are connected with carrier protein BSA respectively and are prepared into PTH antigens.Take pH6.0 0.01mol/L PBS and dimethyl sulfoxide (DMSO) (DMSO) each 0.25mL dissolve 5mg BSA, take MBS 1.2mg to be dissolved in 100 blood DMSO In.MBS is added in BSA liquid 30rnin is stirred at room temperature, upper liquid is left and taken in 4 DEG C of 5000r/min centrifugations.Take PTH (19-29), PTH (51-71) is dissolved in 0.01mol/L pH7.2PBS and DMSO altogether in about 500 μ L respectively.BSA-MBS is mixed with each polypeptide liquid respectively Close, be stirred at room temperature after 60min be stored in -20 DEG C it is standby.
In the present embodiment, the formula of PBS is:0.2mol/L Na2HPO481ml adds 0.2mol/L's Na2HPO419ml is mixed.
2. immune animal prepares monoclonal antibody:
2.1. the PTH antigens (immunogene) of above-mentioned preparation are taken (to be purchased from Shang Haiyuan with isometric Freund's complete adjuvant respectively Poly- biotech firm) be sufficiently mixed after, be immunized Balb/c mouse, 50 μ g antigens/only, subcutaneous multi-point injection.Serum effect is surveyed after 4 weeks Valency, select the good mouse of immunoreactivity booster immunization again:After taking antigen to be sufficiently mixed with isometric incomplete Freund's adjuvant, Only, subcutaneous multi-point injection, the number of booster immunization is 6 times to the μ g/ of antigen dose 25, before fusion continuous booster immunization twice, afterwards Extracting spleen cell is merged with 50%PEG (MW4000) mediations according to a conventional method with Sp2/0 myeloma cell, and is cultivated.Fusion After be put into CO2In incubator after 37 DEG C of cultures 10 days, appearance larger cell clone hole in.Screened with indirect ELISA, it is right The positive hole of primary dcreening operation carries out 4 time cloning cultures (even if a large amount of schizogamies of cell after screening) using limiting dilution assay, it Afterwards amplifying cells, freeze, prepare ascites.
2.2. Balb/c mouse are only handled with norphytane (being purchased from sigma companies) 0.6ml/, pneumoretroperitoneum inoculation in one week is miscellaneous Hand over oncocyte 3 × 106Individual/only, collect ascites after 10 days.
2.3. antibody titer is determined:The monoclonal antibody (1) prepared with indirect ELISA method measure using PTH antigens (1) Potency, as a result show that the potency of monoclonal antibody reaches 1:More than 35000.
The potency of the monoclonal antibody (2) prepared using PTH antigens (2) is also measured using identical method, and it is imitated Valency also reaches 1:More than 33000.
3. immune animal prepares polyclonal antibody:
3.1. male white big ear rabbit 2 is taken, body weight about 2Kg, divides 3 groups, every group 2 at random.With two kinds of PTH polypeptide antigens Every group of rabbit is immunized respectively, using subcutaneous multiple spot skeptophylaxis method.1. fundamental immunity:Every rabbit injection of BCG vaccine 2.5mg is held Continuous 10d;2. Freund's complete adjuvant:Every group of rabbit is injected respectively with 2 kinds of complex immunogens, and 2mg/ rabbit is (each about containing BSA and polypeptide 1mg), pure polypeptide immunogene PTH 1-84 inject 1mg/ rabbit, continue 28d;3. freund 's incomplete adjuvant is immunized:2 kinds of compounds Immunogene injects 1.6mg/ rabbit of every group of rabbit (containing BSA and each about 0.8mg of polypeptide), pure polypeptide immunogene PTH 1-84 notes respectively 0.8mg/ rabbit is penetrated, continues 28d;4. booster immunization:The aqua prepared later with 3 kinds of immunogenes weekly distinguishes booster immunization, agent Amount is the same as 3..
3.2. antibody titer is determined:The polyclonal antibody (1) prepared with indirect elisa method measure using PTH antigens (1) Potency, as a result show that antibody titer reaches 1:More than 28000.
The potency of the polyclonal antibody (2) prepared using PTH antigens (2) is also measured using identical method, and it is imitated Valency also reaches 1:More than 30000.
3.3. blood and separation serum are taken:Arteria carotis intubation takes blood, separates serum.
4. isolate and purify antibody:After ammonium sulfate precipitation, then through Protein G (being purchased from sigma companies) affinity purification.
5. freezed after antibody packing, Cord blood.
Embodiment 3:People PTH antibody (1) and the specificity identification of (2)
Detected with ELISA.It is anti-as detection using people PTH, Actin albumen, neuronspecific enolase NSE respectively Primordial covering elisa plate, detect the special of prepared PTH monoclonal antibodies (1) and (2) and different albumen respectively by ELISA Property reaction, negative control is made with normal BALB/c mouse serum, PBS liquid makees blank control.
As a result:PTH monoclonal antibodies (1) and (2) respectively only and PTH reactions are positive (P/N > 2.1), and with Actin eggs In vain, neuronspecific enolase NSE reactions are feminine gender, illustrate to resist using monoclonal prepared by the PTH epitope peptides of the present invention Body (1) and (2) have specificity respectively.
Identification polyclonal antibody is carried out using with above-mentioned identification monoclonal antibody specificity identical method.
As a result show:PTH polyclonal antibodies (1) and (2) they are respectively positive (P/N > 2.1) with PTH reactions, and and Actin Albumen, neuronspecific enolase NSE reactions are feminine gender, illustrate polyclonal antibody prepared by the PTH epitope peptides of the present invention (1) and (2) have specificity respectively.
Embodiment 4:For detecting the preparation of people PTH fluorescence immune chromatography test paper in determinand
1. research object:Sample comes from 60 surgery patients of Jiang Yuan hospitals, is punctured with syringe art by first shape Gland body of gland, lymph node, musculature, adipose tissue, thyroid glands, thymic tissue sampling are stand-by.
2. reagent and instrument:
Immune chromatography test paper is divided into test group and control group, and the labelled antibody of wherein test group is to utilize this in embodiment 2 The monoclonal antibody of epitope peptide (1) preparation of invention, detection antibody are to be prepared in embodiment 2 using the epitope peptide (2) of the present invention Monoclonal antibody.And control group as labelled antibody and is directed to using the current commercialized PTH antibody for PTH total lengths The antibody of PTH (1-34) epitope is as detection antibody.Quality Control antibody (sheep anti-mouse igg), fluorescent microsphere, fluorescence in immunochromatography Detector comes from Wuxi City Jiang Yuan industry Technology and Trade Co., Ltd, nitrocellulose filter (Merck-Millipore companies of the U.S.), sample Pad, pad, bottom plate, blotting paper are purchased in the outstanding company in Shanghai, CLIA detection kits, Roche Holding Ag's product, other reagents It is pure for domestic analysis.
3. preparation method:
3.1.1 antibody labeling fluorescent microsphere:
Fluorescent microsphere is washed using pH7.2-7.6 MES activation buffers, adds carbodiimide (EDC) and N- hydroxyl ambers Amber acid imide (NHS), certain time is reacted at room temperature, wash fluorescent microsphere, answered with 0.05M pH7.2-7.6 phosphate buffer Labelled antibody is added after molten, is reacted at room temperature 2 hours, adds the phosphate-buffered of the 0.05M pH7.2-7.6 containing 10%BSA Liquid, react at room temperature 30 minutes, fluorescent microsphere is washed, with containing 1%BSA, 0.1%Tween-20,0.05M pH7.2-7.6 phosphorus Phthalate buffer is redissolved to original volume, is quantitatively sprayed on pad, and 35-38 DEG C of lucifuge is dried 1 hour, is added drier and is sealed up for safekeeping It is standby;
3.1.2 fluorescence immune chromatography test paper bar assembling parts are handled:
(1) processing of sample pad
Dried using the phosphate buffer immersion sample of the 0.02M pH7.4 containing 1%BSA, 0.1%Triton100.
(2) preparation of nitrocellulose filter
, respectively will detection antibody and the dilution of Quality Control antibody using the phosphate buffer of the 0.02M pH7.4 containing 1% sucrose To 1mg/ml, the two is sprayed on nitrocellulose filter with 0.5cm interval, addition drier is sealed up for safekeeping standby after drying;
3.1.3 the assembling of fluorescence immune chromatography test paper bar:
It is less than 35%, in the environment of stable 20-25 DEG C in humidity, nitrocellulose filter 2, knot is pasted on PVC bottom plates 1 Closed the pad 5 of fluorescent microsphere mark, sample pad 4 and blotting paper 3 form micro-filtration system, cut into that 0.3cm is wide, and loading is got stuck In i.e. test strips (Fig. 1 and Fig. 2) are made.
4. detection method:
4.1 sampling:By the in vitro doubtful Parathyroid Tissue sub-sampling of 26-gague syringe needles FNA 3, take Syringe needle rear connects 1ml syringes after sample.
4.2 sample pretreatment:A solution conduit for containing 200 μ lPBS buffer solutions is taken, balances to room temperature, institute is ensured before use There is bottom of the liquid all in pipe.Syringe after FNA is stretched into buffer solution, fully washed by Smoking regime mixed It is even, testing sample is made.
4.3 sample-adding:The above-mentioned μ l of testing sample 60 are added in the sample application zone of PTH fluorescence immune chromatography test papers, in incubator Membrane chromatographic reacts 5 minutes.
4.4 detection:By reacted fluorescence immune chromatography test paper and calibration card insertion Portable fluorescence immune quantitative analysis The card inserting mouth of instrument, runs instrument, and the automatic Card Reader of instrument provides quality control band C values and detection band T values in fluorescence immune chromatography test paper.
4.5 results judge:
Work as C<When 10000, it is that invalid detection detects, it is necessary to re-replace test paper to represent result;
It is as a result the positive as T/C >=0.2, shows that it is Parathyroid Tissue to puncture thing;
Work as T/C<It is as a result feminine gender when 0.2, shows to puncture the non-Parathyroid Tissue of thing.
5. the drafting of standard curve:PTH standard items are made 6 different concentration, respectively 0 μ g/L, 10pg/mL, 50pg/ml, 100pg/mL, 200pg/mL, 300pg/mL, each concentration do 5 Duplicate Samples.
6. fluorescence immune chromatography test paper bar performance test:(1) sensitivity:10 blank samples are determined, averages (x) and marks Accurate poor (s), x ± s is calculated, corresponding dosage is found on standard curve with this numerical value.(2) test strips are at 4 DEG C, lucifuge condition The PTH of same batch and different batches fluorescence immune chromatography test paper bar is extracted in lower preservation respectively after 6 months, dense with 100pg/mL The standard items of degree are tested, and calculate crowd interior and difference between batch CV.(3) 6 corresponding with PTH standard curves are made in standard items Individual concentration, carry out specific detection.
7. compared with Electrochemiluminescince (CLIA) detection kit:Operated in strict accordance with CLIA detection kits specification It is required that Parallel testing is carried out to the puncture parathyroid gland sample of 60 patients simultaneously respectively with PTH fluorescence detection tests.
8. statistical procedures:Data are analyzed with the statistical softwares of SPSS 19.0, chi-square criterion is used between group, P values are less than 0.05 is statistically significant.Correlation is carried out with paired-samples T-test and otherness compares.
As a result with analysis:
1. testing result interpretation:During detection, because chromatography application fluids move forward.If PTH content is very few in sample, PTH in sample and then corresponding less, the pad that marks the fluorescent microsphere of antibody binding to combine to form compound C1 on pad In labelled antibody largely combined with the Quality Control antibody on C lines, therefore T lines will be more shallow than C line fluorescence many or can't detect completely Fluorescence, it is as a result feminine gender;If PTH concentration is larger in sample, compound C1 is accordingly more, with the detection antibody knot at T lines Merge a large amount of formation antibody-antigen-antibody compound C2, and PTH is higher in sample, and the colour developing of T lines is deeper, is as a result the positive. Either positive or negative findings, because the fluorescent microsphere of murine antibody mark is excessively coated with, thus always there is uncombined detection The part fluorescent microsphere of antibody is combined with the sheep anti-mouse igg at C lines, occurs the aggregation of fluorescent microsphere at C lines.If C lines do not have There are fluorescent bands, no matter T lines whether there is fluorescent bands, as a result invalid.
2. Specification Curve of Increasing:According to statistical method, to detect fluorescent value signal as ordinate, PTH standard items Concentration is abscissa (table 1 is the data of test group, that is, utilizes the antibody of epitope of the present invention), establishes equation and is fitted to mark Directrix curve.The R of the standard curve2For 0.9996, it is linear preferably, meet the requirement of quantitative detection.And control group is (i.e. using commercially available PTH full length antibodies and PTH 1-34 epitope antibodies) standard curve R2It is linearly poor relative to test group for 0.9207.
The PTH standard items testing results of table 1
3.PTH immunochromatography fluorescent test paper strip performance evaluations:
(1) sensitivity:The zero-dose point average reading of test group is 14.26, and conversion is 0.18pg/ on standard curve mL.0.20pg/mL, 1pg/ml, 2pg/mL, 4pg/mL, 8pg/mL sample is taken to be detected, and it is dense using standard curve progress Degree conversion, it is found that the PTH samples of this series concentration gradient can be detected accurately.And control group is entered using the same manner Row checking, sensitivity are only capable of reaching 2.0pg/mL, the two difference an order of magnitude.
(2) stability and precision:CV values corresponding to the standard curve each group of test group are respectively less than 5% (table 1).4 DEG C, keep away When the ELISA test strip of 6 months is preserved under optical condition, batch in and batch between CV be respectively 4.94% and 5.26%, the results showed that test paper Bar detects stability and precision is preferable.Control group is more or less the same in stability and precision with test group.
(3) it is specific:Carried out the PTH standard items prepared and thyroxine standard items while with the test strips of test group Detection, each concentration point cross reacting rate CR%=measured values thyroxine/measured value PTH × 100%, in above-mentioned concentration range It is interior, 0.1% is respectively less than with the cross reacting rate of thyroxine, illustrates both no cross reactions, method specificity is relatively good.When adopting During with control group test strips, in the cross reacting rate of low concentration point and thyroxine more than 3%, specificity is substantially not as experiment Group.
4. the comparison with CLIA methods:60 patients are punctured with parathyroid gland body of gland, lymph nodes, musculature, fatty group Knit, thyroid glands dilution uses CLIA kits and test group fluorescence immune chromatography test paper bar, control group immunochromatography respectively Test strips are detected, and take serum PTH values upper limit 65pg/mL to be the cut off values of this kit, and analyze data.
As a result show, the coefficient correlation of test group immuno-chromatographic test paper strip and CLIA kits is 0.9951, and correlation is bent Line is Y=0.9793X+1.8376, and the fluorescence immunoassay test strip that wherein Y is the present invention detects obtained PTH concentration (pg/ Ml), X is the PTH concentration (pg/ml) that CLIA kits detect to obtain.It can be seen that both correlations are fine.In addition result is shown just The PTH concentration of normal parathyroid gland and non-Parathyroid Tissue has significant difference (table 2), and P values are less than 0.001, and correlation has Statistical significance.And the coefficient correlation of control group immuno-chromatographic test paper strip and CLIA kits is 0.9176, correlation is compared to examination It is poor to test group.
The different tissues eluent PTH testing results of table 2
From above example and result is investigated, the monoclonal antibody prepared by two PTH epitope peptides of the present invention Energy specific recognition PTH, can be in short time accurate quantitative analysis using fluorescence immune chromatography POCT quantitative detecting methods of its preparation PTH, it is not significantly different with CLIA methods detection acquired results, complies fully with clinical practice requirement, simple to operate, small volume, just In carrying, it is easy to preserve, clinic popularization and application.
Although embodiment of the present invention is disclosed as above, it is not restricted in specification and embodiment listed With.It can be applied to various suitable the field of the invention completely., can be easily for those skilled in the art Realize other modification.Therefore it is of the invention and unlimited under the universal limited without departing substantially from claim and equivalency range In specific details and shown here as the legend with description.

Claims (10)

  1. A kind of 1. method of quick discriminating human parathyroid, it is characterised in that comprise the following steps:
    1) in vitro doubtful Parathyroid Tissue is sampled with syringe needle FNA, connection injection in syringe needle rear after sampling Device;
    2) solution conduit containing PBS is taken, is balanced to room temperature, the syringe after FNA is stretched into buffer solution, passed through Smoking regime fully washs mixing, and testing sample is made;
    3) above-mentioned testing sample is added in the sample application zone of human parathyroid hormone (PTH) fluorescence immune chromatography test paper, in incubator Middle membrane chromatographic reaction;
    4) reacted fluorescence immune chromatography test paper and calibration card are inserted to the card inserting mouth of Portable fluorescence immune quantitative analyzer, Instrument is run, the automatic Card Reader of instrument provides quality control band C values and detection band T values in fluorescence immune chromatography test paper;
    5) C is worked as<When 10000, it is that invalid detection detects, it is necessary to re-replace test paper to represent result;
    It is as a result the positive as T/C >=0.2, shows that it is Parathyroid Tissue to puncture thing;
    Work as T/C<It is as a result feminine gender when 0.2, shows to puncture the non-Parathyroid Tissue of thing.
  2. 2. the method for quick discriminating human parathyroid according to claim 1, it is characterised in that the puncture time in step 1) Number is 3 times, syringe needle 26-gague, and syringe volume is 1ml.
  3. 3. the method for quick discriminating human parathyroid according to claim 1, it is characterised in that in step 2) in solution conduit PBS volume is 200 μ l, and the volume that step 3) adds testing sample is 60 μ l.
  4. 4. the method for quick discriminating human parathyroid according to claim 1, it is characterised in that the fluorescence immune chromatography Test paper by double antibody sandwich method and fluorescence immune chromatography technology for detection people PTH, wherein:
    The double antibody sandwich method is using being marked with the first PTH monoclonal antibodies of fluorescent microsphere as detection antibody, and described the One PTH monoclonal antibodies are prepared by the use of one in people PTH epitope peptides (1) and (2) as antigen;And
    The double antibody sandwich method is utilized using the 2nd PTH monoclonal antibodies as capture antibody, the second monoclonal antibody Another in people PTH epitope peptides (1) and (2) prepares as antigen;
    The people PTH epitope peptides (1) and (2) are respectively:
    (1):ERVEWLRKKLQ(SEQ ID NO:2)
    (2):RKKEDNVLVESHEKSLGEAD(SEQ ID NO:3).
  5. 5. the method for quick discriminating human parathyroid according to claim 1, it is characterised in that the monoclonal antibody is It is prepared by PTH epitope peptides and the antigen that carrier protein couplet is prepared.
  6. 6. the method for quick discriminating human parathyroid according to claim 1, it is characterised in that on the fluorescent microsphere Fluorescent material is rare earth ion europium.
  7. 7. the method for quick discriminating human parathyroid according to claim 1, it is characterised in that the fluorescent microsphere it is micro- Ball material is the copolymer of polystyrene, polymethyl methacrylate or methyl methacrylate.
  8. 8. the method for quick discriminating human parathyroid according to claim 1, it is characterised in that the test paper has bottom plate (1) it is being provided with, and with the way of contact successively along chromatography direction when using on the bottom plate (1):Sample pad (4), pad (5), nitrocellulose filter (2), blotting paper (3), the pad (5) are provided with the first PTH for marking and having Monoclonal antibody, the nitrocellulose filter (2) include detection band (7) and quality control band (6), and the detection band (7) is fixed The 2nd PTH monoclonal antibodies are stated, the quality control band (6), which is coated with, to mark the first PTH monoclonals having with described The antiantibody that antibody specificity combines.
  9. 9. the method for quick discriminating human parathyroid according to claim 8, it is characterised in that the bottom plate (1) does not have There is photoluminescent property.
  10. 10. the method for quick discriminating human parathyroid according to claim 8, it is characterised in that the antiantibody is sheep Anti- mouse IgG polyclonal antibodies or rabbit anti-mouse igg polyclonal antibody.
CN201710650822.8A 2017-08-02 2017-08-02 A kind of method of quick identification human parathyroid Active CN107402300B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710650822.8A CN107402300B (en) 2017-08-02 2017-08-02 A kind of method of quick identification human parathyroid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710650822.8A CN107402300B (en) 2017-08-02 2017-08-02 A kind of method of quick identification human parathyroid

Publications (2)

Publication Number Publication Date
CN107402300A true CN107402300A (en) 2017-11-28
CN107402300B CN107402300B (en) 2019-01-11

Family

ID=60401853

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710650822.8A Active CN107402300B (en) 2017-08-02 2017-08-02 A kind of method of quick identification human parathyroid

Country Status (1)

Country Link
CN (1) CN107402300B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108445237A (en) * 2018-06-20 2018-08-24 广州市康润生物科技有限公司 A kind of new application of PTH tachysynthesises detecting system
CN111334282A (en) * 2020-03-18 2020-06-26 厦门稀土材料研究所 PTH rare earth detection kit, detection card, microspheres thereof, preparation method and detection method
CN113588602A (en) * 2021-07-08 2021-11-02 苏州诺为尔医疗科技有限责任公司 Rapid parathyroid hormone detection method

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105167810A (en) * 2015-09-25 2015-12-23 江苏省原子医学研究所 Puncture outfit used in parathyroid hormone or lymph gland operation
CN205280727U (en) * 2015-10-15 2016-06-01 厦门宝太生物科技有限公司 Fluorescence immunity chromatography test paper
CN205333645U (en) * 2015-12-30 2016-06-22 厦门依柯利斯医疗科技有限公司 Lp -PLA2 quick quantitative detection test paper strip in people's serum
CN205958585U (en) * 2016-08-17 2017-02-15 遂宁市中心医院 Parathyrine detection test strip that determines nature
CN106771128A (en) * 2016-12-15 2017-05-31 威海纽普生物技术有限公司 Parathyroid hormone determines kit and preparation method

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105167810A (en) * 2015-09-25 2015-12-23 江苏省原子医学研究所 Puncture outfit used in parathyroid hormone or lymph gland operation
CN205280727U (en) * 2015-10-15 2016-06-01 厦门宝太生物科技有限公司 Fluorescence immunity chromatography test paper
CN205333645U (en) * 2015-12-30 2016-06-22 厦门依柯利斯医疗科技有限公司 Lp -PLA2 quick quantitative detection test paper strip in people's serum
CN205958585U (en) * 2016-08-17 2017-02-15 遂宁市中心医院 Parathyrine detection test strip that determines nature
CN106771128A (en) * 2016-12-15 2017-05-31 威海纽普生物技术有限公司 Parathyroid hormone determines kit and preparation method

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JENS TAMPE,ET AL: "Characterization of Antibodies Against Human N Terminal Parathyroid Hormone by Epitope Mapping", 《JOURNAL OF IMMUNOASSAY AND IMMUNOCHEMISTRY》 *
王娜 等: "两种PTH载体蛋白连接法的特异抗体及载体抗体比较的初步探讨", 《中华微生物学和免疫学杂志》 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108445237A (en) * 2018-06-20 2018-08-24 广州市康润生物科技有限公司 A kind of new application of PTH tachysynthesises detecting system
CN111334282A (en) * 2020-03-18 2020-06-26 厦门稀土材料研究所 PTH rare earth detection kit, detection card, microspheres thereof, preparation method and detection method
CN111334282B (en) * 2020-03-18 2023-05-26 厦门稀土材料研究所 PTH rare earth detection kit, PTH rare earth detection card, microsphere and preparation and detection methods thereof
CN113588602A (en) * 2021-07-08 2021-11-02 苏州诺为尔医疗科技有限责任公司 Rapid parathyroid hormone detection method
CN113588602B (en) * 2021-07-08 2024-06-04 合肥新唯基因科技有限公司 Rapid parathyroid hormone detection method

Also Published As

Publication number Publication date
CN107402300B (en) 2019-01-11

Similar Documents

Publication Publication Date Title
CN107255726B (en) Quantitatively detect the fluorescence immune chromatography test paper and preparation method thereof of human parathyroid hormone
CN205538992U (en) Test paper dish and test paper tray salver
CN101377501A (en) Cell keratin 19 fragments chemiluminescence immune analysis determination reagent kit and preparing method thereof
EP2631649A1 (en) Method and device for the rapid diagnosis of diseases in faecal samples
CN109188000A (en) A kind of test strips and preparation method thereof of portable inspectiont human parathyroid hormone
CN104422772A (en) Time resolution immunochromatographic test strip for quantitatively detecting pepsinogen I as well as preparation method of time resolution immunochromatographic test strip
CN105717303A (en) Method and reagent kit for detecting phosphatidylinositol proteoglycan 3 with fluorescence immunochromatographic method
CN107402300B (en) A kind of method of quick identification human parathyroid
Alpert Alpha-I-Fetoprotein: Serologic Marker of Hu-man Hepatoma and Embryonal Carcinoma¹2
CN109142758A (en) It is a kind of to detect the immuno-chromatographic test paper strip of glycosylated hemoglobin, kit and preparation method thereof
CN106959372A (en) Serum amyloid A protein and the two-in-one measure kit of C reactive proteins and preparation method
CN107110847A (en) For detecting or measuring the ethyl glucuronide aldehydic acid glycosides lateral flow calibration tape of ethyl glucuronide aldehydic acid glycosides, immunoassays, apparatus and method
CN110361547A (en) The reagent and its detection method of a kind of chemiluminescence quantitative detection fecal occult blood and its detection lower digestive tract health purposes
CN103969447A (en) Vascular endothelial growth factor quantitative determination kit and light-emitting substrate solution thereof
CN205484371U (en) Tumour mark detect reagent box
CN107703110A (en) G17 detection kit and preparation method thereof
CN106872716A (en) Serum amyloid A protein and two-in-one measure kit and the preparation method of Procalcitonin
US11067579B2 (en) Target marker GP73 for detecting steatohepatitis and detection application method
CN113109560A (en) Test strip for quickly testing flonicamid pesticide, preparation method and detection method thereof
CN108802367A (en) A kind of chemical luminescence ELISA detection kit of vancomycin
CN111879924A (en) Colloidal gold immunochromatography test paper for rapidly diagnosing hemoglobin and combining globin-hemoglobin compound and preparation method thereof
CN110275014B (en) Method for rapidly identifying metastasis of papillary thyroid carcinoma cervical lymph nodes in operation
CN106053824A (en) Pancreas cancer duplex detection kit
CN101963618B (en) Method for identifying heterophilic antibody interference in antibody microarray system and antibody microarray chip using same for detecting target antigen
CN105296520A (en) Preparation method and enzyme-linked immunosorbent assay kit of human tumor antigen 3H11Ag

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20201216

Address after: 214063 Jiangsu city of Wuxi province Qian Rong Lu No. 20

Patentee after: WUXI JIANGYUAN INDUSTRIAL TECHNOLOGY AND TRADE Corp.

Address before: 214063 Jiangsu city of Wuxi province Qian Rong Lu No. 20

Patentee before: JIANGSU INSTITUTE OF NUCLEAR MEDICINE

CP01 Change in the name or title of a patent holder
CP01 Change in the name or title of a patent holder

Address after: 214063 Jiangsu city of Wuxi province Qian Rong Lu No. 20

Patentee after: Wuxi Jiangyuan industrial technology and Trade Co.,Ltd.

Address before: 214063 Jiangsu city of Wuxi province Qian Rong Lu No. 20

Patentee before: WUXI JIANGYUAN INDUSTRIAL TECHNOLOGY AND TRADE Corp.